Bacterial two-component signalling as a therapeutic target in drug design. Inhibition of NRII by the diphenolic methanes (bisphenols).
Domagala JM, Alessi D, Cummings M, Gracheck S, Huang L, Huband M, Johnson G, Olson E, Shapiro M, Singh R, Song Y, Van Bogelen R, Vo D, Wold S.
Domagala JM, et al. Among authors: huang l.
Adv Exp Med Biol. 1998;456:269-86. doi: 10.1007/978-1-4615-4897-3_14.
Adv Exp Med Biol. 1998.
PMID: 10549373
Review.
No abstract available.